We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

106 hedge funds and large institutions have $308M invested in Voyager Therapeutics in 2023 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 36 increasing their positions, 21 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 16

71% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 21

68% more capital invested

Capital invested by funds: $184M → $308M (+$124M)

40% more call options, than puts

Call options by funds: $1.27M | Put options by funds: $913K

31% more funds holding

Funds holding: 81 → 106 (+25)

6.72% more ownership

Funds ownership: 55.01% → 61.73% (+6.7%)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
106
Holders Change
+25
Holders Change %
+30.86%
% of All Funds
1.66%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
41
Increased
36
Reduced
21
Closed
16
Calls
$1.27M
Puts
$913K
Net Calls
+$361K
Net Calls Change
+$1.05M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$17.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$5.29M
3
Morgan Stanley
Morgan Stanley
New York
+$5.21M
4
FCM
Farallon Capital Management
California
+$5.12M
5
State Street
State Street
Massachusetts
+$4.66M

Top Sellers

Rank Fund Capital Flow
1
TGI
TRV GP III
Massachusetts
-$24.6M
2
Millennium Management
Millennium Management
New York
-$11.9M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.64M
4
Jane Street
Jane Street
New York
-$1.32M
5
Goldman Sachs
Goldman Sachs
New York
-$949K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$2.19M +$961K +92,926 +94%
EI
27
EAM Investors
California
$2.15M +$659K +63,684 +51%
Arrowstreet Capital
28
Arrowstreet Capital
Massachusetts
$1.84M +$1.66M +160,477 New
Walleye Capital
29
Walleye Capital
New York
$1.72M +$1.55M +150,028 New
Connor, Clark & Lunn Investment Management (CC&L)
30
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.27M +$1.98K +191 +0.2%
SCM
31
Silverarc Capital Management
Massachusetts
$1.15M +$1.03M +100,000 New
American Century Companies
32
American Century Companies
Missouri
$1.14M +$1.03M +99,440 New
GGHC
33
Gilder Gagnon Howe & Co
New York
$1.08M -$23K -2,226 -2%
N
34
Nuveen
North Carolina
$1.01M +$915K +88,425 New
Charles Schwab
35
Charles Schwab
California
$974K +$751K +72,609 +583%
Goldman Sachs
36
Goldman Sachs
New York
$944K -$949K -91,691 -53%
Wellington Management Group
37
Wellington Management Group
Massachusetts
$923K +$834K +80,586 New
Manulife (Manufacturers Life Insurance)
38
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$896K +$13.1K +1,269 +2%
Fidelity Investments
39
Fidelity Investments
Massachusetts
$809K +$7.2K +696 +1%
Deutsche Bank
40
Deutsche Bank
Germany
$778K +$148K +14,276 +27%
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$766K -$2.64M -254,917 -79%
TD Asset Management
42
TD Asset Management
Ontario, Canada
$764K +$129K +12,451 +23%
BFM
43
Boothbay Fund Management
New York
$700K +$510K +49,324 +417%
PHP
44
Parkman Healthcare Partners
Connecticut
$663K +$599K +57,881 New
Two Sigma Investments
45
Two Sigma Investments
New York
$657K +$325K +31,395 +121%
Blackstone Inc
46
Blackstone Inc
New York
$582K +$167K +16,129 +46%
CAM
47
ClariVest Asset Management
California
$564K +$510K +49,300 New
Jane Street
48
Jane Street
New York
$523K -$1.32M -127,258 -74%
TI
49
Trexquant Investment
Connecticut
$507K +$458K +44,252 New
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$474K +$428K +41,411 New
1
2
3 4 5

VYGR Hedge Fund Activity: Q2 2023 in Review

106 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q2 2023, worth a combined $308M — up 68% from $184M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new VYGR positions and 16 closed out — a net gain of 25 holders — while 36 added to existing stakes and 21 trimmed.

The largest buyer was BlackRock, adding an estimated $17.1M. The largest seller was TRV GP III, exiting entirely with an estimated $24.6M sold.

  • 106 institutional investors held Voyager Therapeutics (VYGR) as of Q2 2023, up from 81 in Q1 2023.
  • Funds reported $308M of Voyager Therapeutics stock for Q2 2023, up 68% quarter-over-quarter.
  • 41 funds opened new Voyager Therapeutics positions in Q2 2023 and 16 closed out, a net change of +25 holders.
  • The largest Voyager Therapeutics buyer in Q2 2023 was BlackRock, an estimated $17.1M added.
  • The largest Voyager Therapeutics seller in Q2 2023 was TRV GP III, an estimated $24.6M sold.

Based on aggregated 13F filings for Q2 2023.